𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Testosterone replacement in prostate cancer survivors with hypogonadal symptoms

✍ Scribed by Robert L. Leibowitz; Tanya B. Dorff; Steven Tucker; James Symanowski; Nicholas J. Vogelzang

Book ID
109056244
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
212 KB
Volume
105
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Testosterone replacement for hypogonadis
Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy
✍ Michael F. Sarosdy πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Controversy and a notable paucity of published clinical data best characterize the current knowledge of testosterone‐replacement therapy (TRT) for hypogonadism after treatment for early, localized prostate cancer. The objective of this study was to assess the risk of bio

Effect of exogenous testosterone replace
Effect of exogenous testosterone replacement on prostate-specific antigen and prostate-specific membrane antigen levels in hypogonadal men
✍ Thomas H. Douglas; Roger R. Connelly; David G. McLeod; Sheila J. Erickson; Rober πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 424 KB

Previous studies have suggested that serum prostate-specific antigen (PSA) levels are under androgenic influence, especially in patients with adenocarcinoma of the prostate. PSMA (prostate-specific membrane antigen) is thought to reflect hormonal or clonal resistance or an independence with respect